Article Details

Ambrx Biopharma IPO Priced at Middle of Expectations >AMAM

Retrieved on: 2021-06-18 09:56:39

Tags for this article:

Click the tags to see associated articles and topics

Ambrx Biopharma IPO Priced at Middle of Expectations >AMAM. View article details on hiswai:

Excerpt

The La Jolla, Calif., clinical-stage biopharmaceutical company said it expects gross proceeds of $126 million, adding that it granted the underwriters a 30 ...

Article found on: www.marketwatch.com

View Original Article

This article is found inside other hiswai user's workspaces. To start your own collection, sign up for free.

Sign Up
Book a Demo